Stonepine Capital Management »

Adlai Nortye Ltd Sponsored shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Adlai Nortye Ltd Sponsored (ANL) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Adlai Nortye Ltd Sponsored

Tip: Access up to 7 years of quarterly data

All positions including Adlai Nortye Ltd Sponsored held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adlai Nortye Ltd Sponsored by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $279k 24k 11.50

More positions owned by Stonepine Capital Management

Evolus (EOLS)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Nektar Therapeutics Com New (NKTR)
Ultragenyx Pharmaceutical (RARE)
Camp4 Therapeutics Corp Com 13469v Ab 4 Camtek Ltd Note 12/0 (CAMP)
Insmed Com Par $.01 Call Option (INSM)
Eloxx Pharmaceuticals Com New
Kazia Therapeutics Sponsored Ads (KZIA)
Medtronic SHS Call Option (MDT)
Indivior Pharmaceuticals (INDV)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Abbott Laboratories Call Option (ABT)
Satellos Bioscience (MSLE)

View all positions for Stonepine Capital Management

Top funds holding Adlai Nortye Ltd Sponsored

Cormorant Asset Management
VR Adviser
Balyasny Asset Management
Point72 Asset Management
MPM Oncology Impact Management
Perceptive Advisors
Casdin Capital
ADAR1 Capital Management
Octagon Capital Advisors
Millennium Management
Braidwell
Squadron Capital Management
Eventide Asset Management
Superstring Capital Management
Adage Capital Partners GP

View all funds holding Adlai Nortye Ltd Sponsored